TLR4 and epilepsy: Activation of the innate immune system, such as the application of the TLR4 agonist LPS, is known to be potently epileptogenic in mouse models, and chronic inflammation has been implicated in mesial temporal lobe epilepsy with hippocampal sclerosis, a frequently occurring, acquired type of epilepsy [49].